Nuveen, LLC Blueprint Medicines Corp Transaction History
Nuveen, LLC
- $315 Billion
- Q1 2025
A detailed history of Nuveen, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Nuveen, LLC holds 267,660 shares of BPMC stock, worth $27.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
267,660Holding current value
$27.3 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
400Shares Held
62.5MCall Options Held
1.62MPut Options Held
1.43M-
Black Rock Inc. New York, NY6.65MShares$677 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$676 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$578 Million0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY2.51MShares$255 Million0.02% of portfolio
-
State Street Corp Boston, MA2.5MShares$255 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $6.08B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...